Some reasons for the lack of progress in the treatment of acute myelogenous leukemia: a review of three consecutive trials of the treatment of poor prognosis patients. [electronic resource]
Producer: 19911114Description: 773-80 p. digitalISSN:- 0145-2126
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow -- drug effects
- Cell Cycle
- Cell Division -- drug effects
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Drug Resistance
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Remission Induction
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.